Why the study?
Does bosentan pretreatment alter the hemodynamic responses to angiotensin II in normotensive and hypertensive rats?
Does bosentan pretreatment alter the hemodynamic responses to angiotensin II in normotensive and hypertensive rats?
Endothelin contributes to the hemodynamic effects of Angiotensin II, particularly in spontaneously hypertensive rats, suggesting a role in exaggerated pressor responsiveness.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for endothelin modulation of Ang II effects in hypertension; leaves open human translation.
We determined changes in blood pressure, cardiac output, and total peripheral conductance evoked by intravenous infusions of angiotensin II (Ang II) in conscious, unrestrained normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) before and after pretreatment with bosentan, a nonselective endothelin antagonist. Blood pressure was recorded by radiotelemetry and cardiac output by ultrasonic transit-time flow probes. Bosentan per se failed to affect basal blood pressure and evoked only small changes in cardiac output and total peripheral conductance in both strains. The pressor effects of Ang II were exaggerated in SHR compared with WKY. Strikingly, bosentan pretreatment blunted the increases in blood pressure, the fall in cardiac output, and the decreases in conductance evoked by lower doses of Ang II but not higher doses of the peptide. This effect was observed in both rat strains but was more pronounced in SHR. These data suggest that endothelin contributes to the hemodynamic effects of Ang II in both SHR and WKY and that endothelin may contribute to the exaggerated pressor responsiveness of SHR to Ang II.
No takes yet. Share an insight, caveat, or question.
Balakrishnan et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: